Letter: Psychological remission - A future endpoint in inflammatory bowel disease? Authors' reply

Alimentary Pharmacology and Therapeutics

Volumn 39, Issue 12, 2014, Pages 1436-1437

  Panara, A J ^a   Yarur, A J ^a   Sussman, D A ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PSYCHOTROPIC AGENT;

DISEASE ACTIVITY; DISEASE ASSOCIATION; HUMAN; INFLAMMATORY BOWEL DISEASE; LETTER; MENTAL HEALTH; OUTCOME ASSESSMENT; PATIENT REPORTED OUTCOME; PRIORITY JOURNAL; PSYCHOLOGICAL REMISSION; PSYCHOTHERAPY; QUALITY OF LIFE; REMISSION; SOCIAL PSYCHOLOGY; TREATMENT OUTCOME; CROHN DISEASE; DEPRESSION; FEMALE; MALE; NOTE; ULCERATIVE COLITIS;

COLITIS, ULCERATIVE; CROHN DISEASE; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; PSYCHOTROPIC DRUGS;

EID: 84901361111     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12784     Document Type: Letter

References (4)

1. Barreiro-de Acosta M, Gisbert JP,. Letter: psychological remission-a future endpoint in inflammatory bowel disease? Aliment Pharmacol Ther 2014; 39: 1436.
2. Williet N, Sandborn WJ, Peyrin-Biroulet L,. Patient-Reported Outcomes as Primary End Points in Clinical Trials of Inflammatory Bowel Disease. Clin Gastroenterol Hepatol 2014; doi: 10.1016/j.cgh.2014.02.016 [Epub ahead of print].
3. Kappelman MD, Long MD, Martin C, et al,. Evaluation of the Patient-Reported Outcomes Measurement Information System in a Large Cohort of Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol 2013; doi: 10.1016/j.cgh.2013.10.019 [Epub ahead of print].
4. Panara AJ, Yarur AJ, Rieders B, et al,. The incidence and risk factors for developing depression after being diagnosed with inflammatory bowel disease: a cohort study. Aliment Pharmacol Ther 2014; 39: 802-10.